Replies to post #143708 on OWC Pharmaceutical Research Corp (OWCP)

[I-Glow]

Whoever told you to post this provided you with the pinkyland fantasy information - that isn't accurate.

Claim: “The massive dilution has begun with the filing of Form 424B3!”

Claim Rejected Priced at 0.2 and 0.22

I suggest you read the documents much more closely before posting.

Damn, this is going to hurt - from Form 424B3:

You will experience dilution of your ownership interest because of the future issuance of additional shares of our common stock or our preferred stock.

In the future, we may issue our authorized but previously unissued equity securities, including shares of our common stock, resulting in the dilution of the ownership interests of our present shareholders. We are authorized to issue an aggregate of 500,000,000 shares of common stock, par value $0.00001 per share and 20,000,000 shares of preferred stock, par value $0.00001. As of May 31, 2018, 147,758,908 shares of our common stock are outstanding and 500 shares of our Series A Preferred Stock are outstanding. In addition, current holders of our common stock will experience dilution in their equity ownership from the exercise of outstanding common stock purchase warrants and stock options granted under our 2016 Employees Stock Option Plan (the “2016 ESOP”).

This is what is so funny - OWCP tells the shareholders they are going to experience dilution but those in pinky fantasyland - ignore the facts.

I doubt any OWCP shareholders has read all of the SEC filings.

IG